P38 MAP kinase inhibitors for the treatment of arthritis

被引：0
|
作者：
Barlocco, D
Langston, S
机构：
[1] Univ Milan, I-20131 Milan, Italy
[2] Millennium Pharmaceut, Merrifield Ctr, Cambridge CB1 3LQ, England
来源：
DRUG DISCOVERY TODAY | 2001年 / 6卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：808 / 809
页数：2
相关论文
共 50 条
  • [41] 4-azaindoles: Novel inhibitors of p38 MAP kinase.
    Trejo, A
    Arzeno, H
    Browner, M
    Cheng, SA
    Corner, DD
    Dalrymple, S
    Freire-Moar, J
    Lim, J
    Mcintosh, J
    Miller, J
    Myers, PL
    Saunders, J
    Sjogren, EB
    Spellmyer, D
    Warren, SD
    Whiteley, PE
    Zeng, L
    Goldstein, DM
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U59 - U59
  • [42] Binding modes of known classes of p38 MAP kinase inhibitors.
    Moss, N
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U437
  • [43] Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons
    Zawada, WM
    Meintzer, MK
    Rao, P
    Marotti, J
    Wang, XM
    Esplen, JE
    Clarkson, ED
    Freed, CR
    Heidenreich, KA
    [J]. BRAIN RESEARCH, 2001, 891 (1-2) : 185 - 196
  • [44] Identification of p38α MAP kinase inhibitors by pharmacophore based virtual screening
    Gangwal, Rahul P.
    Das, Nihar R.
    Thanki, Kaushik
    Damre, Mangesh V.
    Dhoke, Gaurao V.
    Sharma, Shyam S.
    Jain, Sanyog
    Sangamwar, Abhay T.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 49 : 18 - 24
  • [45] Design, synthesis, and SAR of a novel series of p38α MAP kinase inhibitors
    Martin, Barrie P.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [46] Quantitative structure activity relationship study of p38α MAP kinase inhibitors
    Pourbasheer, Eslam
    Ahmadpour, Sajjad
    Zare-Dorabei, Rohollah
    Nekoei, Mehdi
    [J]. ARABIAN JOURNAL OF CHEMISTRY, 2017, 10 (01) : 33 - 40
  • [47] SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity
    Revesz, L
    Blum, E
    Di Padova, FE
    Buhl, T
    Feifel, R
    Gram, H
    Hiestand, P
    Manning, U
    Rucklin, G
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3601 - 3605
  • [48] Synthesis and SAR of p38α MAP kinase inhibitors based on heterobicyclic scaffolds
    Dhar, T. G. Murali
    Wrobleski, Stephen T.
    Lin, Shuqun
    Furch, Joseph A.
    Nirschl, David S.
    Fan, Yi
    Todderud, Gordon
    Pitt, Sidney
    Doweyko, Arthur M.
    Sack, John S.
    Mathur, Arvind
    McKinnon, Murray
    Barrish, Joel C.
    Dodd, John H.
    Schieven, Gary L.
    Leftheris, Katerina
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5019 - 5024
  • [49] P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis
    Kimberly K Brown
    Sandra A Heitmeyer
    Erin B Hookfin
    Lily Hsieh
    Maria Buchalova
    Yetunde O Taiwo
    Michael J Janusz
    [J]. Journal of Inflammation, 5
  • [50] Kinetic mechanism for p38 MAP kinase
    LoGrasso, PV
    Frantz, B
    Rolando, AM
    OKeefe, SJ
    Hermes, JD
    ONeill, EA
    [J]. BIOCHEMISTRY, 1997, 36 (34) : 10422 - 10427
12345